Cambridge, United Kingdom

Michael Skynner

USPTO Granted Patents = 10 

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Skynner

Introduction

Michael Skynner, an accomplished inventor based in Cambridge, GB, holds an impressive portfolio of 10 patents. His work primarily revolves around the development of novel polypeptides and their applications in treating significant medical conditions. His inventive spirit has led to groundbreaking solutions in the healthcare arena.

Latest Patents

Among his latest patents are two notable inventions:

1. **Bicyclic peptide ligands specific for P-selectin** - This invention encompasses polypeptides that are covalently attached to molecular scaffolds with multiple peptide loops. The primary focus is on peptides that bind to P-selectin, paving the way for drug conjugates aimed at preventing or treating diseases mediated by cell adhesion molecules like P-selectin, which includes vaso-occlusive crises and conditions related to sickle cell disease, cancer, and COVID-19.

2. **Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)** - Similar to his first patent, this invention details polypeptides binding to TfR1. It also covers multimeric binding complexes and their pharmaceutical applications in delivering therapeutic agents effectively.

Career Highlights

Michael Skynner has made a significant impact in the pharmaceutical industry through his innovative work. He has contributed his expertise to companies such as Bicycletx Limited and Bicyclerd Limited, focusing on the research and development of advanced therapeutic solutions. His ability to merge scientific rigor with creativity has positioned him as a leading figure in his field.

Collaborations

Throughout his career, Michael has collaborated with esteemed professionals, including Gemma Elizabeth Mudd and Katerine Van Rietschoten. Together, they have worked on various projects that further innovate the landscape of medical therapies and drug design.

Conclusion

Michael Skynner’s extensive contributions to patents in the realm of peptide ligands showcase his commitment to advancing therapeutic options for critical medical challenges. With a strong foundation in innovative research and strategic collaborations, he continues to make strides in the healthcare sector, exemplifying the role of inventors in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…